Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/3015% above fair value
$4.13−0.28 (-6.35%)
Close on Nov 13, 2026Market cap $100.05MP/E –Yield –
Exagen gross margin
Gross margin is gross profit as a percentage of revenue.
Exagen's gross margin for the twelve months ending Sep 30, 2026 was 58.7%. For fiscal 2025 it was 58.3%, against 59.5% the year before. The highest annual figure on record is 60.6% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 58.3% | −1.2 |
| FY2024 | Dec 31, 2024 | 59.5% | +3.5 |
| FY2023 | Dec 31, 2023 | 56.1% | +9.2 |
| FY2022 | Dec 31, 2022 | 46.9% | −10.5 |
| FY2021 | Dec 31, 2021 | 57.4% | −3.2 |
| FY2020 | Dec 31, 2020 | 60.6% | +7.1 |
| FY2019 | Dec 31, 2019 | 53.4% | +0.8 |
| FY2018 | Dec 31, 2018 | 52.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 58.8% | +0.4 |
| Q2 FY2026 | Jun 30, 2026 | 61.3% | +0.8 |
| Q1 FY2026 | Mar 31, 2026 | 59.0% | +0.1 |
| Q4 FY2025 | Dec 31, 2025 | 55.4% | −6.7 |
| Q3 FY2025 | Sep 30, 2025 | 58.4% | +2.6 |
| Q2 FY2025 | Jun 30, 2025 | 60.4% | +0.3 |
| Q1 FY2025 | Mar 31, 2025 | 58.9% | −0.8 |
| Q4 FY2024 | Dec 31, 2024 | 62.1% | +2.9 |
| Q3 FY2024 | Sep 30, 2024 | 55.8% | −1.6 |
| Q2 FY2024 | Jun 30, 2024 | 60.1% | +1.4 |
| Q1 FY2024 | Mar 31, 2024 | 59.6% | +12.4 |
| Q4 FY2023 | Dec 31, 2023 | 59.2% | +8.3 |
| Q3 FY2023 | Sep 30, 2023 | 57.4% | −1.7 |
| Q2 FY2023 | Jun 30, 2023 | 58.7% | +38.6 |
| Q1 FY2023 | Mar 31, 2023 | 47.2% | +3.2 |
| Q4 FY2022 | Dec 31, 2022 | 50.9% | −10.2 |
| Q3 FY2022 | Sep 30, 2022 | 59.2% | +4.0 |
| Q2 FY2022 | Jun 30, 2022 | 20.1% | −37.2 |
| Q1 FY2022 | Mar 31, 2022 | 44.0% | −11.5 |
| Q4 FY2021 | Dec 31, 2021 | 61.1% | −4.7 |
| Q3 FY2021 | Sep 30, 2021 | 55.2% | −4.5 |
| Q2 FY2021 | Jun 30, 2021 | 57.3% | −5.4 |
| Q1 FY2021 | Mar 31, 2021 | 55.5% | +2.9 |
| Q4 FY2020 | Dec 31, 2020 | 65.8% | +139.1 |
| Q3 FY2020 | Sep 30, 2020 | 59.7% | −36.5 |
| Q2 FY2020 | Jun 30, 2020 | 62.7% | +10.4 |
| Q1 FY2020 | Mar 31, 2020 | 52.6% | +0.5 |
| Q4 FY2019 | Dec 31, 2019 | -73.4% | −131.8 |
| Q3 FY2019 | Sep 30, 2019 | 96.2% | +43.0 |
| Q2 FY2019 | Jun 30, 2019 | 52.3% | – |
| Q1 FY2019 | Mar 31, 2019 | 52.0% | – |
| Q4 FY2018 | Dec 31, 2018 | 58.5% | – |
| Q3 FY2018 | Sep 30, 2018 | 53.2% | – |
See a number that looks wrong?